© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
InspireMD, Inc. (NSPR) stock surged +1.28%, trading at $0.79 on NASDAQ, up from the previous close of $0.78. The stock opened at $0.78, fluctuating between $0.77 and $0.81 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 0.80 | 0.81 | 0.77 | 0.79 | 31.96K |
| Sep 10, 2026 | 0.80 | 0.80 | 0.75 | 0.78 | 39K |
| Sep 09, 2026 | 0.82 | 0.85 | 0.76 | 0.79 | 48.64K |
| Sep 08, 2026 | 0.83 | 0.86 | 0.81 | 0.83 | 72.35K |
| Sep 04, 2026 | 0.84 | 0.90 | 0.83 | 0.85 | 30.33K |
| Sep 03, 2026 | 0.90 | 0.90 | 0.84 | 0.84 | 28.91K |
| Sep 02, 2026 | 0.90 | 0.90 | 0.84 | 0.84 | 66.12K |
| Sep 01, 2026 | 0.86 | 0.91 | 0.85 | 0.91 | 45.75K |
| Aug 31, 2026 | 0.90 | 0.93 | 0.87 | 0.89 | 72.61K |
| Aug 28, 2026 | 0.88 | 0.90 | 0.83 | 0.85 | 74.27K |
| Aug 27, 2026 | 0.90 | 0.95 | 0.86 | 0.89 | 23.05K |
| Aug 26, 2026 | 0.90 | 0.92 | 0.89 | 0.89 | 35.21K |
| Aug 25, 2026 | 0.85 | 0.95 | 0.85 | 0.92 | 49.94K |
| Aug 24, 2026 | 0.88 | 0.89 | 0.86 | 0.87 | 113.07K |
| Aug 21, 2026 | 0.89 | 0.90 | 0.85 | 0.90 | 83.91K |
| Aug 20, 2026 | 0.91 | 0.92 | 0.86 | 0.90 | 46.81K |
| Aug 19, 2026 | 0.86 | 0.97 | 0.85 | 0.91 | 102.47K |
| Aug 18, 2026 | 0.88 | 0.93 | 0.85 | 0.88 | 74.22K |
| Aug 17, 2026 | 0.95 | 1.00 | 0.81 | 0.88 | 526.48K |
| Aug 14, 2026 | 0.85 | 1.02 | 0.85 | 0.98 | 429.1K |
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.
| Employees | 127 |
| Beta | 0.82 |
| Sales or Revenue | $6.21M |
| 5Y Sales Change% | -0.998% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |